Thomson Reuters
    EN : JP : CN : KR : ES : PT   
 
 
 
Newport Vision CI™


 
API Intelligence

Newport Vision CI™
is the critical competitive intelligence and global business development system from Thomson, the industry authority on the global generics market.

Created specifically to address the needs of research-based innovator, specialty and niche-brand pharmaceutical companies, Newport Vision CI™ ensures you don't miss the developing generic competition that can impact your sales, or the opportunity that can build on your strengths.



KEY ADVANTAGES & BENEFITS

  • Sales, launch, approval and regulatory date for more than 10,000 launched products
  • Unique, early API manufacturing intelligence
  • Worldwide patent families and individual patents for more than 90 countries
  • Comprehensive Supplementary Protection Certificate (SPC) data for Europe
  • Projected loss of exclusivity dates for US, EU and Japanese markets
  • Sales figures by molecule and by dosage form for major world market regions, including two-year sales history
  • NEW Launched does and pack price data from over 65 markets, India and China recently added
  • Paragraph IV patent challenges commentaries, including company identities, FTF and status of litigation for more than 100 active cases
  • Product launch and first market authorization data, country-by-country
  • Orange book approved dose forms, US Drug Master Files, EU Certificates of Suitability and FDA warning letters and issues
  • Labelling and prescribing data for more than 1,800 unique products
  • Chemical structure diagram and details of alternative structures for thousands of products
  • Powerful indexing and searching of products according to FDA approved indication and technology class
  • NEW Product search by CAS® Registry Number as well as by brand or API name
  • NEW Target product search or target company search by Corporate Group Location
  • NEW Target product search by number of Unexpired Orange Book Patents
  • Profiles of more than 12,000 companies and corporate groups, including subsidiary, launch, approvals, regulatory filings and APIs manufactured
  • Detailed manufacturing capabilities for an increasing number of sites
  • Alerting on key changes in products and companies, including new regulatory filings and approvals
  • Up-to-the-minute integrated news from Thomson Dialog®
  • NEW Reports on various generic conferences

INTENDED USERS

Competitive intelligence and business intelligence departments — Quickly assess competitive landscape for individual products and groups of products, or across therapy areas, competitor products, and companies

Product management, lifecycle management teams — Improve planning and management of product life cycles by understanding the anticipated timing and intensity of generic competition

Legal, and intellectual property professionals — Detect and interpret early warning signs of patent challenges and patent circumvention attempts

Business development and licensing departments — Profile competitors, business partners, and candidate products for acquisition, alliances, licensing, or supply, and manufacture purposes





associated products  
 
 
 


 

Simple deployment across your enterprise
  • Easy-to-use web-based interface
  • Zero-cost deployment with secure, confidential access
  • Integrated on-line help, including full glossary and FAQs
  • Comprehensive training and technical support
  • Monthly intelligence updates
  • Flexible licensing options

Contact information
Thomson Reuters
215 Commercial Street
Portland, Maine 04101
Phone: 207-871-9700
Fax: 207-871-9800
Email

System requirements

Additional Newport Vision CI information
API Manufactures Click here to update your information

Click here to download the latest Newport Vision CI fact sheet

 
Disclaimer | Terms of Use
Privacy Policy | Copyright